PSA vs SER · rev $4.82B vs rev $56.0K
PSA (PSA) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
PSA (PSA) common stock.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
PSA currently screens at market cap $0. SER currently screens at market cap $29.7M.
Not investment advice. Open the PSA and SER stock pages for the full models.
Not investment advice.